Cutting costs and Copaxone prices pays off for Teva, sending shares skywardadmin 3rd May 2018 Uncategorised 0
You could say Teva investors are pleasantly surprised. The embattled drugmaker’s shares soared 8% Thursday morning after showing signs that restructuring and cost-cutting plans laid out in November were working. But thanks to Copaxone copies, the pressure’s still on.
More: Cutting costs and Copaxone prices pays off for Teva, sending shares skyward